Mystery Behind Barrett's Esophagus: The Origin and Malignant Transformation of Esophageal Adenocarcinoma
Diao Xiayao
Mystery Behind Barrett's Esophagus: The Origin and Malignant Transformation of Esophageal Adenocarcinoma
[1] |
Sung H, Ferlay J, Siegel RL.et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(03): 209-249
|
[2] |
Jiang D, Zhang L, Liu W.et al.Trends in cancer mortality in China from 2004 to 2018: a nationwide longitudinal study. Cancer Commun (Lond) 2021; 41(10): 1024-1036
|
[3] |
He Y, Liang D, Du L.et al.Clinical characteristics and survival of 5283 esophageal cancer patients: a multicenter study from eighteen hospitals across six regions in China. Cancer Commun (Lond) 2020; 40(10): 531-544
|
[4] |
Patel N, Benipal B.Incidence of esophageal cancer in the United States from 2001-2015: a United States cancer statistics analysis of 50 states. Cureus 2018; 10(12): e3709
|
[5] |
Qiu H, Cao S, Xu R.Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond) 2021; 41(10): 1037-1048
|
[6] |
Sawas T, Killcoyne S, Iyer PG. et al. OCCAMS Consortium. Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts. Gastroenterology2018; 155 (06): 1720-1728.e4
|
[7] |
Lu L, Mullins CS, Schafmayer C, Zeißig S, Linnebacher M.A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun (Lond) 2021; 41(11): 1137-1151
|
[8] |
Nowicki-Osuch K, Zhuang L, Jammula S.et al.Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition. Science 2021; 373(6556): 760-767
|
[9] |
Jiang M, Li H, Zhang Y.et al.Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus. Nature 2017; 550(7677): 529-533
|
[10] |
Wang X, Ouyang H, Yamamoto Y.et al.Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145(07): 1023-1035
|
[11] |
Leedham SJ, Preston SL, McDonald SA. et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 2008; 57(08): 1041-1048
|
[12] |
Owen RP, White MJ, Severson DT.et al.Single cell RNA-seq reveals profound transcriptional similarity between Barrett's oesophagus and oesophageal submucosal glands. Nat Commun 2018; 9(01): 4261
|
[13] |
Wang S, Zhan M, Yin J.et al.Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 2006; 25(23): 3346-3356
|
[14] |
Rogerson C, Britton E, Withey S, Hanley N, Ang YS, Sharrocks AD.Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its precancerous precursor state. Genome Res 2019; 29(05): 723-736
|
[15] |
Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, Brigham and Women's Hospital, Broad Institute, Brown University, Case Western Reserve University, Dana-Farber Cancer Institute, Duke University, Greater Poland Cancer Centre, Harvard Medical School, Institute for Systems Biology, KU Leuven, Mayo Clinic, Memorial Sloan Kettering Cancer Center, National Cancer Institute, Nationwide Children's Hospital, Stanford University, University of Alabama, University of Michigan, University of North Carolina, University of Pittsburgh, University of Rochester, University of Southern California, University of Texas MD Anderson Cancer Center, University of Washington, Van Andel Research Institute, Vanderbilt University, Washington University, Genome Sequencing Center: Broad Institute, Washington University in St. Louis, Genome Characterization Centers: BC Cancer Agency, Broad Institute, Harvard Medical School, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of North Carolina, University of Southern California Epigenome Center, University of Texas MD Anderson Cancer Center, Van Andel Research Institute, Genome Data Analysis Centers: Broad Institute, Brown University, Harvard Medical School, Institute for Systems Biology, Memorial Sloan Kettering Cancer Center, University of California Santa Cruz, University of Texas MD Anderson Cancer Center, Biospecimen Core Resource: International Genomics Consortium, Research Institute at Nationwide Children's Hospital, Tissue Source Sites: Analytic Biologic Services, Asan Medical Center, Asterand Bioscience, Barretos Cancer Hospital, BioreclamationIVT, Botkin Municipal Clinic, Chonnam National University Medical School, Christiana Care Health System, Cureline, Duke University, Emory University, Erasmus University, Indiana University School of Medicine, Institute of Oncology of Moldova, International Genomics Consortium, Invidumed, Israelitisches Krankenhaus Hamburg, Keimyung University School of Medicine, Memorial Sloan Kettering Cancer Center, National Cancer Center Goyang, Ontario Tumour Bank, Peter MacCallum Cancer Centre, Pusan National University Medical School, Ribeirão Preto Medical School, St. Joseph's Hospital &Medical Center, St. Petersburg Academic University, Tayside Tissue Bank, University of Dundee, University of Kansas Medical Center, University of Michigan, University of North Carolina at Chapel Hill, University of Pittsburgh School of Medicine, University of Texas MD Anderson Cancer Center, Disease Working Group: Duke University, Memorial Sloan Kettering Cancer Center, National Cancer Institute, University of Texas MD Anderson Cancer Center, Yonsei University College of Medicine, Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health. Integrated genomic characterization of oesophageal carcinoma. Nature 2017; 541(7636): 169-175
|
/
〈 | 〉 |